BackX.T.L. Biopharmaceuticals Overview

X.T.L. Biopharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for XTLB.

Quarterly EBIT

-$479.00K
↓ 158.13% YoY

As of Dec 31, 2024

Annual EBIT (TTM)

-$2.01M
↓ 877.61% YoY

Trailing 12 months ending Dec 31, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin